Adriamycin, mitomycin C, and 5-fluorouracil in combination for advanced colorectal adenocarcinoma previously treated with 5-fluorouracil

M. A. Kessinger, J. F. Foley, H. M. Lemon

Research output: Contribution to journalArticle

Abstract

Twenty-one patients with progressing colorectal carcinoma previously treated with 5-FU were given a combination of 5-FU, adriamycin, and mitomycin C in an attempt to produce an objective response. No response was observed; 24% of patients had an arrest of their disease for a median of 18 weeks. 5-FU, adriamycin, and mitomycin C in combination failed to produce a response in patients with colorectal carcinoma previously treated with 5-FU.

Original languageEnglish (US)
Pages (from-to)317-319
Number of pages3
JournalCancer Clinical Trials
Volume2
Issue number4
StatePublished - Dec 1 1979

Fingerprint

Mitomycin
Fluorouracil
Doxorubicin
Adenocarcinoma
Colorectal Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Adriamycin, mitomycin C, and 5-fluorouracil in combination for advanced colorectal adenocarcinoma previously treated with 5-fluorouracil. / Kessinger, M. A.; Foley, J. F.; Lemon, H. M.

In: Cancer Clinical Trials, Vol. 2, No. 4, 01.12.1979, p. 317-319.

Research output: Contribution to journalArticle

@article{e988dad9c6374b70b0d4260d7f01bb84,
title = "Adriamycin, mitomycin C, and 5-fluorouracil in combination for advanced colorectal adenocarcinoma previously treated with 5-fluorouracil",
abstract = "Twenty-one patients with progressing colorectal carcinoma previously treated with 5-FU were given a combination of 5-FU, adriamycin, and mitomycin C in an attempt to produce an objective response. No response was observed; 24{\%} of patients had an arrest of their disease for a median of 18 weeks. 5-FU, adriamycin, and mitomycin C in combination failed to produce a response in patients with colorectal carcinoma previously treated with 5-FU.",
author = "Kessinger, {M. A.} and Foley, {J. F.} and Lemon, {H. M.}",
year = "1979",
month = "12",
day = "1",
language = "English (US)",
volume = "2",
pages = "317--319",
journal = "American Journal of Clinical Oncology",
issn = "0277-3732",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Adriamycin, mitomycin C, and 5-fluorouracil in combination for advanced colorectal adenocarcinoma previously treated with 5-fluorouracil

AU - Kessinger, M. A.

AU - Foley, J. F.

AU - Lemon, H. M.

PY - 1979/12/1

Y1 - 1979/12/1

N2 - Twenty-one patients with progressing colorectal carcinoma previously treated with 5-FU were given a combination of 5-FU, adriamycin, and mitomycin C in an attempt to produce an objective response. No response was observed; 24% of patients had an arrest of their disease for a median of 18 weeks. 5-FU, adriamycin, and mitomycin C in combination failed to produce a response in patients with colorectal carcinoma previously treated with 5-FU.

AB - Twenty-one patients with progressing colorectal carcinoma previously treated with 5-FU were given a combination of 5-FU, adriamycin, and mitomycin C in an attempt to produce an objective response. No response was observed; 24% of patients had an arrest of their disease for a median of 18 weeks. 5-FU, adriamycin, and mitomycin C in combination failed to produce a response in patients with colorectal carcinoma previously treated with 5-FU.

UR - http://www.scopus.com/inward/record.url?scp=0018740465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018740465&partnerID=8YFLogxK

M3 - Article

C2 - 394867

AN - SCOPUS:0018740465

VL - 2

SP - 317

EP - 319

JO - American Journal of Clinical Oncology

JF - American Journal of Clinical Oncology

SN - 0277-3732

IS - 4

ER -